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ORIGINAL ARTICLE
Central diabetes insipidus (DI) is a sign of brain
death and a well-recognized entity in brain-dead
organ donors. It can develop after severe brain
injury,1,2 and is also seen in patients with 
hypoxic encephalopathy.3 Hypopituitarism is
seldom described in brain death or hypoxic en-
cephalopathy because these patients usually die
soon after the precipitating event. Anterior pitu-
itary function is usually preserved in these pa-
tients several days after brain death.4 However,
this could be caused by the compressive effects
of severe brain swelling on the pituitary gland
rand also occur during brain hypoperfusion afte
brain death.
cAlthough brain death equates with somati
death in Taiwan, the decision to classify brain
death in an individual only applies to a potential
rorgan donor whose family is willing and unde
conditions that comply with related laws. In
Taiwan, the family usually requests continued
life support and emphasizes bodily preservation
even after somatic death.
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Background/Purpose: c Central diabetes insipidus (DI) is an established phenomenon after hypoxi
encephalopathy or brain death, but hypopituitarism is seldom described. This study investigated the charac-
teristics of 11 patients with DI and hypopituitarism which developed after severe hypoxic encephalopathy.
Methods: yThe medical records of patients with DI and hypopituitarism after severe hypoxic encephalopath
from 1997 to 2002 were retrospectively reviewed. Eleven patients with DI and hypopituitarism after severe
hypoxic episodes were included. Demographic data, primary diagnosis, the time of onset of DI, the time
of diagnosis of hypopituitarism, the presence of symptoms of hypopituitarism, and outcome of these patients
were analyzed.
Results: Eleven patients comprising nine females and two males aged 47.4 ± 19.3 years (range, 24–74
years) were included. The mean interval from the precipitating event to the onset of DI was 60 ± 46 hours
(range, 11–131 hours). The mean interval from the precipitating event to the diagnosis of hypopituitarism
was 423 ± 182 hours (range, 132–672 hours). The average duration of hospitalization was 63 ± 35 days
(range, 9–113 days). The overall mortality rate during hospitalization was 45%. Four patients died of sepsis
and one died of heart failure due to acute myocardial infarction.
Conclusion: The development of DI after severe hypoxic encephalopathy is a sign of severe brain damage.
It usually ensues immediately or days after loss of brain stem reflexes. Hypopituitarism developed several
weeks later than DI in these patients. Recognition and treatment of these deficiencies may prevent organ
dysfunction. [J Formos Med Assoc 2006;105(7):536–541]
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The purpose of this study was to analyze the
clinical presentation of adults with DI and hypo-
pituitarism related to severe hypoxic encephalo-
pathy after prolonged life support. Recognition
and control of these conditions are required to
prevent organ dysfunction before organ donation.
Methods
An archival search was performed to identify all
patients with the diagnosis of DI combined with
hypopituitarism in National Taiwan University
Hospital from 1997 to 2002. Cases with DI and
hypopituitarism after severe hypoxic encephalo-
pathy were included in this study. Severe hypoxic
encephalopathy was defined as a Glascow Coma
Scale score of less than six points combined with
lack of brain stem reflexes and spontaneous respi-
ratory drive after a hypoxic/ischemic brain insult.
Brain stem damage was found in these patients,
but apnea test for brain death was not performed.
Inclusion criteria were clinical and biochemical
evidence of DI and hypopituitarism after severe
hypoxic encephalopathy. Eleven patients were in-
cluded, and their medical records were reviewed.
The following information was obtained for
each patient: primary diagnosis, age, sex, pres-
ence or absence of symptoms of hypopitu-
itarism, symptoms of DI, the interval from the
precipitating insult to onset of DI, the interval
from the precipitating insult to clinical diagnosis
of hypopituitarism. The clinical diagnosis of DI
was based on the development of polyuria with
urine output of more than 4 mL/kg/hr for at least
3 hours, low urinary specific gravity (< 1.010), and
low urine osmolality (<300 mOsm/kg). Confirma-
tion of DI was obtained by control of polyuria
and hypernatremia with desmopressin acetate
(DDAVP) administration.5
Hypopituitarism was diagnosed if the follow-
ing conditions were found: low plasma adrenocor-
ticotropic hormone/serum cortisol, thyrotropin/
free thyroxine (T4) levels and symptoms of hy-
popituitarism, such as late-onset wide swings in
blood pressure and hypotension, hypoglycemia,
hyponatremia, bradycardia, and hypothermia.
Inotropic agents, including dopamine, epineph-
rine, and norepinephrine, were used in these pa-
ftients to sustain their vital signs. The dosages o
inotropic agents were titrated according to indi-
vidual needs.
Results
Eleven patients with DI combined with hypopi-
 tuitarism were included. They consisted of nine
females and two males aged 47.4 ± 19.3 years
 (range, 24–74 years). The etiologies of severe
hypoxic encephalopathy included subarachnoid
hemorrhage in five patients, ischemic cerebral
vascular accident in two, intracranial hemor-
rhage in one, acute myocardial infarction with
ventricular fibrillation in one, near-drowning in
one and thyroid storm with hyperosmolar non-
ketoic syndrome in one (Table 1). Cardiorespira-
tory arrest occurred in nine patients and lasted
5–30 minutes. The mean interval from the pre-
cipitating event to the loss of brain stem reflexes
was 43 ± 37 hours (range, 3–108 hours). The
mean interval from the precipitating event to the
onset of DI was 60 ± 46 hours (range, 11–131
hours). Hypernatremia occurred in conjunction
with polyuria in most patients (64%). The mean
interval from the precipitating event to the diag-
nosis of hypopituitarism was 423 ± 182 hours
(range, 132–672 hours). Hypopituitarism usu-
fally occurred 1–4 weeks after the development o
gDI, and 9 days to 1 month after the precipitatin
event. All patients with suspected hypopitu-
itarism had late-onset hypotension (Table 2).
Hyponatremia (55%) and hypothermia (55%)
were also common, while bradycardia (9%) and
hypoglycemia (18%) were found less often.
The mean interval of hospitalization was 63 ±
35 days (range, 9–113 days). Ten patients survived
for more than 1 month under combination ther-
apy of desmopressin and inotropic agents. The
overall mortality rate was 45% during hospitaliza-
ftion. Four patients died of sepsis and one died o
heart failure due to acute myocardial infarction.
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The other six patients were transferred to chronic
care units and died 106 ± 99 days later (range,
28–288 days).
Discussion
Myers and Yamaguchi described two patterns of
injury in the brain of the rhesus monkey depending
on whether the interruption of blood flow was par-
tial or total. Total arrest of the circulation or total
asphyxia primarily produced damages to the brain
stem, including necrosis of the motor nuclei, infe-
rior colliculi, superior olives, vestibular nuclei, and
thalamus. In contrast, partial impairment of the
circulation or partial oxygen deprivation resulted
in predominantly hemispheric damage.6,7 In the
present study, the patterns of brain damage were





Interval from Interval from injury
Hospital
Outcome
Stay at chronic Loss of brain
no. (yr)
injury to to diagnosis of
stay (d) care unit (d) stem reflex (hr)
DI onset (hr) hypopituitarism (hr)
1 F 24 Thyroid storm 131 230 32 Death/sepsis – 54
2 F 24 Near-drowning 120 480 37 Death/sepsis – Unknown*
3 F 30 Ischemic CVA 37 492 105 Transfer 151 96
4 F 40 SAH 12 216 55 Transfer 41 3
5 M 37 AMI 40 132 9 Death/heart failure – 108
6 F 44 SAH 68 480 49 Transfer 69 18
7 F 43 SAH 11 432 99 Transfer 59 15
8 M 60 SAH 24 644 62 Death/sepsis – 60
9 F 71 SAH 18 642 99 Transfer 288 12
10 F 74 ICH 120 624 113 Death/sepsis – 48
11 F 74 Ischemic CVA 72 288 34 Transfer 28 18
*The second patient was brain dead when she was transferred from another hospital, so we could not accurately determine the time of severe brain injury.
DI= diabetes insipidus; CVA= cerebral vascular accident; SAH= subarachnoid hemorrhage; AMI= acute myocardial infarction; ICH= intracranial hemorrhage.
Table 2. Basal plasma/serum adrenal and thyroid hormone levels and clinical presentation of 11 patients after brain injury
before hormone replacement therapy
Case
ACTH* Cortisol* TSH* Free T4*
Hypotension Hyponatremia Bradycardia Hypoglycemia Hypothermia
no.
pmol/L μmol/L μU/L pmol/L
2.2–13.2 0.14–0.70 0.45–4.5 10.2–23.4
1 3.4 0.16 0.007 3.6 + 126 + + +
2 1.3 0.01 0.045 5.3 + 129 − − −
3 2.2 0.15 0.002 6.8 + 119 − − −
4 0.9 0.14 0.236 3.9 + 117 − − +
5 2.5 0.06 1.580 – + – − − +
6 1.9 0.15 0.053 4.4 + – − − +
7 3.2 0.25 0.074 5.5 + 110 − − +
8 2.2 0.04 0.034 3.7 + – + − −
9 0.6 0.17 0.004 5.8 + – − − +
10 2.8 0.23 1.010 7.4 + 125 − − −
11 0.5 0.08 0.073 6.7 + – − − −
*Plasma ACTH level was measured by sequential immunometric assay with chemiluminescent substrate (Diagnostic Products Corporation (DPC), CA,
USA). Serum cortisol level was measured by competitive immunoassay with DPC kits. TSH level was measured by a solid-phase, two-sided chemilumines-
cent immunometric assay with DPC kits. Free T4 level was measured by a solid-phase, chemiluminescent, competitive analog immunoassay with DPC kits.
ACTH = adrenocorticotropic hormone; TSH = thyroid stimulating hormone; T4 = thyroxine.
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similar to the brain stem injury caused by total
interruption of blood flow in rhesus monkeys.
Many kinds of brain injuries are associated
with DI, including subarachnoid hemorrhage,
hypoxemic encephalopathy, and diabetic ketoaci-
dosis.8–10 These different brain injuries may share
a common pathway to cause posterior pituitary
dysfunction. The supraoptic and paraventricular
nuclei are markedly resistant to the arrest of cere-
bral circulation and hypoxemia because the neuro-
hypohyseal system has many neurosecretory cells
and an intricate bilateral blood supply.3 Nearly
complete loss of hypothalamic neurons is neces-
sary to cause DI. It has been previously demon-
strated that the development of experimental DI
in dogs or monkeys is associated with a loss of
90% of the neurosecretory cells, indicating that the
appearance of DI following brain injuries denotes
widespread neurologic damage.1 DI developed in
all of our patients, implying the presence of very
severe brain damage.
Brain death is a condition of severe brain dam-
age and could follow hypoxic encephalopathy.
In previous studies, DI occurred in 11.1–87% of
patients with brain death.2,5,11–14 Osmotic diuresis
due to hyperglycemia or manitol use, hypothermia
and lack of renovascular tone may contribute to
polyuria in brain-dead patients, but central eti-
ologies may be more likely to produce polyuria
in these patients.5 However, a consensus for the
definition and diagnosis of DI in these patients
remains to be established.
The interval of onset of DI is variable, ranging
from immediately after the insult to approximately
a week later.1 In some experimental models, a sig-
nificant decrease in hypophyseal hormone pro-
duction was observed in 15–45 minutes, and
polyuria occurred within 45 minutes after brain
death.5 In a human study, the interval from injury
to the onset of DI was 10–240 hours and the in-
terval from the onset of DI to death was 16–168
hours.1 A similar result emerged from another
study in which 14 patients (87%) developed 
DI at or near the time when brain death was
confirmed. Their DI occurred 2–168 hours after
the precipitating injury.14 In another study, the
mean interval between the hypoxic insult and
the onset of DI was 4.07 days and ranged from
2 hours to 13 days. The majority (86%) of patients
c developed DI within 6 days after the hypoxi
insult.3
In this study, the interval from injury to the
onset of DI ranged from 11 to 131 hours, and DI
occurred at or near the time when signs of brain
death were recorded. No definite tests for brain
rdeath were conducted in these patients, as thei
tfamilies insisted on maintaining all life-suppor
measures. The classification of brain death was
made only for potential donors, because physi-
cians in Taiwan do not have the authority to ter-
tminate life support if family members do no
want the patients to be organ donors.
Treatment of DI could be beneficial for brain-
dead patients to decrease the need for large volume
infusion, to correct electrolyte imbalance, and to
improve hemodynamic stability.15 Desmopressin
has been given to brain-dead donors to limit the
harmful effects of DI and it did not have any sub-
stantial effects on graft function in recipients.15
Urine specific gravity is the most sensitive param-
eter to monitor the treatment in patients with
central DI.16 In the present study, desmopressin
appeared to be effective for the control of polyuria
and hypernatremia.
A previous study showed that anterior and
posterior pituitary functions were impaired in 
the early stage after brain death. Antidiuretic hor-
mone and thyroid-stimulating hormone levels 
decreased first. Low serum triiodothyronine (T3)
yand prolactin levels were also noted in the earl
stage of brain death.17 Sick euthyroid syndrome
was usually detected in the early stage of brain
death.4 In the present study, the 5th case had nor-
mal serum thyrotropin and low T3/T4 levels.
Sick euthyroid syndrome is a likely explanation
for this condition, since this patient only lived
y9 days after the onset of hypoxic encephalopath
due to ventricular fibrillation. The other patients
developed hypopituitarism weeks after severe
rbrain injuries, usually more than 9 days afte  
the hypoxic insult, suggesting that it was a late
sequela of severe hypoxic encephalopathy.
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Arita et al18 found that the average blood levels
of anterior pituitary hormones in 13 brain-dead
patients were within normal ranges at the diagno-
sis of the brain death. However, only LH reserve
was maintained in three cases, FSH reserve in three
cases, and TSH reserve in one case by dynamic
tests. Nishioka et al found that basal ACTH and
cortisol levels could be normal initially after 
brain death, but corticotropin-releasing hormone
(CRH) stimulation tests were nonresponsive in
these cases.19,20 Anterior pituitary releasing hor-
mone tests could be useful in the diagnosis of 
hypopituitarism in these patients. Desmopressin,
which has an action similar to CRH, was shown 
to be capable of stimulating ACTH and cortisol 
release when administered alone as a bolus in over
50% of healthy subjects.21 On the other hand, cen-
tral DI is associated with increased baseline ACTH
and cortisol levels and increased responsiveness of
ACTH and cortisol to CRH administration. How-
ever, replacement treatment with desmopressin
normalized CRH-induced but not baseline ACTH
and cortisol secretion in patients with central
DI.22 Thus, measurement of plasma ACTH and
serum cortisol levels before and after the use of
desmopressin may not be useful for the diagnosis
of hypopituitarism in these patients.
Iwai et al showed that combination therapy
with epinephrine and vasopressin could maintain
hemodynamic stability in brain-dead patients
for more than 1 month.23 The majority (91%) of 
our patients survived for more than 1 month
under combination therapy of inotropic agents,
desmopressin and hormone replacement with
steroids and T4. This suggests that hormone re-
placement may help these patients sustain vital
signs. A high prevalence of serious infection was
noted in patients with hypopituitarism.24 In this
study, there was a high rate of mortality (45%)
and sepsis was the major cause (80%) of death.
In the head-injured population, the onset
time of DI is < 3 days in nonsurvivors and weeks
to months for survivors. The development of DI
after head injury carried a 69% mortality rate,
and if the onset was within the first 3 days after
injury, the mortality rate rose to 86%.25 Anterior
pituitary dysfunction was usually found dur-
ing long-term follow-up of these patients.26 The
tshortest reported duration for the developmen
 of hypopituitarism following head injury was
3 weeks.27 In these different severe brain injuries,
DI usually occurred after the precipitating insult,
especially in nonsurvivors or brain-dead patients.
 Hypopituitarism was a late sequela in these
patients if they survived.
yT3 deficiency, present in 85% of donors, ma
tcontribute to donor heart dysfunction after hear
transplantation in recipients with end-stage cardio-
myopathy, and in recipients who have undergone
cardiopulmonary bypass. T3 can be used effect-
ively to resuscitate selected donor hearts with
poor function and in recipients to improve myocar-
dial aerobic metabolism. In addition, T3 decreases
both the amount and duration of inotropic sup-
port.28 yAs with T3 deficiency, hypopituitarism ma
be harmful to donor organ function and needs
to be treated.
Conclusion
DI is a sequela of severe hypoxic encephalopathy.
It usually develops immediately or days after the
loss of brain stem reflexes. Hypopituitarism can
develop several weeks after the onset of DI.
Desmopressin, inotropic agents, and hormone
replacement may allow these patients to survive
 for more than 1 month and prevent organ
dysfunction.
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